This is the Source Data of the paper titled “Influence of Patient Characteristics on Chimeric Antigen Receptor T Cell Therapy in B-cell Acute Lymphoblastic Leukemia”.
Supplementary Videos 1A&B: Real-time imaging of nfP2X7-M CAR-T cell adhesion to and transmigration through blood vessels in vivo. For intravital microscopy, 2x106 MDA-MB-231-LM2 cells expressing G
Chimeric antigen receptor engineered T cell (CAR-T) immunotherapy has shown efficacy against a subset of hematological malignancies1,2, yet its autologous nature and ineffectiveness against epithelial
Introduction: CAR-T cell therapy, emerging as an efficient treatment option for patients with secondary central nervous system (CNS) lymphoma, is frequently complicated with immune effector cell-assoc
